Anzeige
Mehr »
Login
Montag, 20.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 905265 | ISIN: SE0000135485 | Ticker-Symbol: 27R
Frankfurt
17.05.24
09:10 Uhr
12,000 Euro
+1,480
+14,07 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
RAYSEARCH LABORATORIES AB Chart 1 Jahr
5-Tage-Chart
RAYSEARCH LABORATORIES AB 5-Tage-Chart
RealtimeGeldBriefZeit
11,96012,14019.05.
PR Newswire
48 Leser
Artikel bewerten:
(0)

RaySearch Laboratories: RaySearch and C-RAD sign collaboration agreement

STOCKHOLM, May 4, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy.

The focus of the collaboration is to investigate how the C-RAD surface scanning technologies can be utilized during treatment planning in RaySearch's treatment planning system RayStation®*. Today, the surfaces from the C-RAD surface guided radiation therapy system, Catalyst+, are used during imaging and treatment. Making the Catalyst+ surfaces available in RayStation has many potential applications. One such application is to extend a cone beam CT image that has a limited field-of-view by using information from the surface scanning. This will lead to more complete representation of the patient's anatomy, which in turn results in a more dependable basis for clinical decisions. As a first outcome of the announced collaboration, the above-described application will be demonstrated at the ongoing trade show ESTRO, with a continuation to explore other applications of the companies' respective products.

Cecilia de Leeuw, CEO and President, C-RAD, says: "We are thrilled about the collaboration with RaySearch, where we will enhance and find new innovative solutions in our common fight against cancer.

Johan Löf, founder and CEO, RaySearch, says: "I look forward to collaborating with C-RAD, which is also located close to us in Sweden. The additional information about the patient's anatomy provided by surface scanning from Catalyst+ has the potential to greatly improve different steps in the radiation therapy treatment planning process in RayStation."

CONTACT:

For more information, please contact:
[email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/raysearch-laboratories/r/raysearch-and-c-rad-sign-collaboration-agreement,c3973231

The following files are available for download:

https://mb.cision.com/Main/1102/3973231/2778007.pdf

RaySearch Press Release May 4, 2024

https://news.cision.com/raysearch-laboratories/i/press-release-1200x620-c-rad,c3296639

Press-release 1200x620 C RAD

SOURCE RaySearch Laboratories

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2024 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.